[The phospholipid spectrum of platelet membranes in patients with COPD in the abating exacerbation phase]
Related Experiment Video
Updated: Oct 4, 2026

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
Published on: June 10, 2025
Abstract:
Clinical and laboratory studies have been performed in 120 patients with chronic obstructive diseases of the lung (CODL) and in 35 healthy individuals in order to determine the content of different phospholipid fractions in the platelet membranes and their proportions at the beginning of their medical rehabilitation after pulmonological hospital treatment (recurrent exacerbation). It has been found that membranosystemic disorders in CODL represent a major pathogenetic link in the vicious circle of disease progression and the routine therapy is low effective and has no membrane-repairing effect. This makes it necessary to develop and search for new pathogenetic treatments of CODL, which are to exert a membranotropic effects on the whole body.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease II: Emphysema
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History